|dc.description.abstract||CC2D1A is an evolutionarily conserved gene from worm to human. It belongs to a new protein family with four DM14 domains at the NH2 terminus and a C2 domain at the COOH terminus. The function of this protein family remains largely unknown. CC2D1A has been identified as a new NF-κB activator through a large scale screen of human genes by Matsuda et al. Here I show that the conserved DM14 and C2 domains of CC2D1A are important for NF-κB activation. CC2D1A activates the IKK complex and NF-κB target genes through several key components in the canonical pathway including ubiquitin-conjugating enzyme UBC13, a RING domain ubiquitin ligase TRAF2, a protein kinase TAK1, and an essential regulator of IKK complex, NEMO. CYLD, a deubiquitination enzyme specific for Lysine-63 linked polyubiquitin chains, negatively regulates the activity of CC2D1A. These results suggest that CC2D1A activates NF-κB through the canonical IKK pathway.
In an attempt to identify the physiological function of CC2D1A, I generated CC2D1A knockout mice. The KO animals die right after birth apparently due to their inability to breathe. Histological analysis identified no significant anatomical defects. In particular, brain, heart and muscle are normal with regard to morphology. In addition, neuromuscular junction at the diaphragm is formed in the absence of Cc2d1a. Human patients with mutations in the gene suffer from mental retardation, implying that Cc2d1a functions in the central nervous system (CNS). Here I show that Cc2d1a expression is enriched in the brain. Deletion of Cc2d1a impairs synapse maturation and function in cortical neurons. Our study may help understand the molecular basis of some human diseases such as mental retardation.||en